Literature DB >> 22843488

Anti-TNF therapy in women with rheumatoid arthritis with a history of carcinoma in situ of the cervix.

Louise Kate Mercer, Audrey Sze Lin Low, James B Galloway, Kath D Watson, Mark Lunt, Deborah P M Symmons, Kimme L Hyrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22843488     DOI： 10.1136/annrheumdis-2012-201814

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Dejan Micic; Yuga Komaki; Aleksandar Alavanja; David T Rubin; Atsushi Sakuraba
Journal:  J Clin Gastroenterol       Date:  2019-01       Impact factor: 3.062

Review 2.  A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy.

Authors:  Peter K K Wong; Hanish Bagga; Claire Barrett; Geoff Chong; Patrick Hanrahan; Teja Kodali; Mona Marabani; H Miles Prince; John Riordan; Phillip Swarbrick; Ray White; Laurel Young
Journal:  Curr Rheumatol Rep       Date:  2018-09-01       Impact factor: 4.592

Review 3.  [Gynecological cancers in patients with inflammatory rheumatic diseases].

Authors:  M Schmalzing; M Krockenberger; A Honig; H-P Tony
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

Review 4.  [Medication treatment of rheumatoid arthritis with a history of malignancy. Epidemiological data].

Authors:  M Schmalzing; A Strangfeld; H-P Tony
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

5.  -308 G/A TNF-α gene polymorphism influences the course of basal cell carcinoma in a Polish population.

Authors:  Michał Sobjanek; Monika Zabłotna; Igor Michajłowski; Bogusław Nedoszytko; Aleksandra Lesiak; Roman Nowicki
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

6.  Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor.

Authors:  Joung-Liang Lan; Chun-Hung Tseng; Jiunn-Horng Chen; Chi-Fung Cheng; Wen-Miin Liang; Gregory J Tsay
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 7.  Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

Authors:  Katelynn M Wilton; Eric L Matteson
Journal:  Rheumatol Ther       Date:  2017-05-15

8.  Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database.

Authors:  Xavier Mariette; Florence Tubach; Raphaele Seror; Alexandre Lafourcade; Yann De Rycke; Sandrine Pinto; Johann Castaneda; Bruno Fautrel
Journal:  RMD Open       Date:  2022-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.